Wu Y - Search Results

1

Fatal interstitial lung disease induced by rituximab-containing chemotherapy, treatment with TNF-α antagonist and cytokine profiling: a case-report and review of the literature.

Wu Y, Jia Y, Xu J, Shuai X, Wu Y. Wu Y, et al. J Clin Pharm Ther. 2013 Jun;38(3):249-53. doi: 10.1111/jcpt.12052. Epub 2013 Mar 18. J Clin Pharm Ther. 2013. PMID: 23506410

2

[Study on the differentiation of K562 cell-line induced by Tanshinone II A].

Wu Y, Yang Y, Meng W, Li Y, Jia Y, Liu T. Wu Y, et al. Hua Xi Yi Ke Da Xue Xue Bao. 2002 Jan;33(1):80-3. Hua Xi Yi Ke Da Xue Xue Bao. 2002. PMID: 12599436 Chinese.

3

[MMP-9 expression profile in inflammatory cells of Mip-1alpha knockout mice and Mip-1alpha receptor knockout mice].

Wu Y, Mukaida N, Liu T, Jia YQ, Zhu HL, Yang YM, Xu CG, Hu ZX. Wu Y, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 May;40(3):374-7. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009. PMID: 19626984 Chinese.

4

Angioimmunoblastic T-cell lymphoma with coexisting plasma cell myeloma: a case report and review of the literature.

Xu J, Tang Y, Zhao S, Zhang W, Xiu Y, Liu T, Wu Y. Xu J, et al. Among authors: wu y. Tohoku J Exp Med. 2015 Apr;235(4):283-8. doi: 10.1620/tjem.235.283. Tohoku J Exp Med. 2015. PMID: 25816919 Free article. Review.

5

Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.

Zhang L, Pan L, Xiang B, Zhu H, Wu Y, Chen M, Guan P, Zou X, Valencia CA, Dong B, Li J, Xie L, Ma H, Wang F, Dong T, Shuai X, Niu T, Liu T. Zhang L, et al. Among authors: wu y. Oncotarget. 2016 May 24;7(21):30876-91. doi: 10.18632/oncotarget.9021. Oncotarget. 2016. PMID: 27129167 Free PMC article.

6

Late-onset Hemochromatosis: Co-inheritance of β-thalassemia and Hereditary Hemochromatosis in a Chinese Family: A Case Report and Epidemiological Analysis of Diverse Populations.

Yang J, Lun Y, Shuai X, Liu T, Wu Y. Yang J, et al. Among authors: wu y. Intern Med. 2018 Dec 1;57(23):3433-3438. doi: 10.2169/internalmedicine.8628-16. Epub 2017 Sep 25. Intern Med. 2018. PMID: 28943547 Free PMC article.

7

Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy.

Li Q, Huang J, Ou Y, Li Y, Wu Y. Li Q, et al. Among authors: wu y. Immunotherapy. 2019 Mar;11(4):265-272. doi: 10.2217/imt-2018-0083. Epub 2019 Jan 4. Immunotherapy. 2019. PMID: 30606076

8

Acquired persistently complete remission by decitabine-based treatment for acute myeloid leukemia with the MLL-SEPT9 fusion gene.

Wang F, Chen Y, Jiang N, Gong S, Cao T, Yuan J, Liu J, Xie L, Wu Y, Jia Y. Wang F, et al. Among authors: wu y. Leuk Lymphoma. 2019 Dec;60(13):3304-3307. doi: 10.1080/10428194.2019.1625044. Epub 2019 Jul 1. Leuk Lymphoma. 2019. PMID: 31256701 No abstract available.

9

Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults.

Liu P, Pan X, Chen C, Niu T, Shuai X, Wang J, Chen X, Liu J, Guo Y, Xie L, Wu Y, Liu Y, Liu T. Liu P, et al. Among authors: wu y. Blood. 2020 Mar 12;135(11):826-833. doi: 10.1182/blood.2019003886. Blood. 2020. PMID: 31914172 Free article.

10

Low-dose ruxolitinib shows effective in treating myelofibrosis.

Yang Y, Luo H, Zheng Y, Zou Z, Niu T, Jia Y, Zhu H, Liu T, Wu Y, Chang H, Ji J, Li J, Pan L. Yang Y, et al. Among authors: wu y. Ann Hematol. 2021 Jan;100(1):135-141. doi: 10.1007/s00277-020-04311-z. Epub 2020 Oct 20. Ann Hematol. 2021. PMID: 33083863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85,153 results

Search Page

Filters